MedTrace Logo

Retinoblastoma Patient Clinical Database and Tissue Repository

NCT04959097 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-04-22

No results posted yet for this study

Summary

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed.

Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

Conditions

  • Retinoblastoma
  • Retinoblastoma Bilateral
  • Retinoblastoma Unilateral

Sponsors & Collaborators

Principal Investigators

  • Jesse L Berry, MD · Children's Hospital Los Angeles

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04959097 on ClinicalTrials.gov